CN1973778A - Method of predicting serious complication risk degree after gastric cancer operation - Google Patents
Method of predicting serious complication risk degree after gastric cancer operation Download PDFInfo
- Publication number
- CN1973778A CN1973778A CNA2006100982903A CN200610098290A CN1973778A CN 1973778 A CN1973778 A CN 1973778A CN A2006100982903 A CNA2006100982903 A CN A2006100982903A CN 200610098290 A CN200610098290 A CN 200610098290A CN 1973778 A CN1973778 A CN 1973778A
- Authority
- CN
- China
- Prior art keywords
- dissection
- combined
- group
- risk
- gastric cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供了一种客观、量化、精确度高的胃癌术后严重并发症风险度的预测方法。该方法包括以下步骤:(1)通过全面的单因素分析,筛选出对胃癌术后严重并发症有影响的若干因素,(2)通过二值多元非条件逻辑回归分析确定真正影响预后的决定因素,(3)通过受试者工作特征曲线分析,确定最佳的预测值分界值,(4)建立以主要危险因素为自变量的预测模型,通过预测概率来判断病人术后发生严重并发症的风险度。本发明是一种高精确度、全面客观、易操作、智能化的风险评估系统。
The invention provides an objective, quantified and highly accurate method for predicting the risk of serious complications after gastric cancer surgery. The method includes the following steps: (1) through comprehensive univariate analysis, several factors that have an impact on severe complications after gastric cancer surgery are screened out; (2) through binary multiple unconditional logistic regression analysis, the determinants that really affect the prognosis are determined (3) Determine the cut-off value of the best predictive value through receiver operating characteristic curve analysis, (4) Establish a predictive model with major risk factors as independent variables, and judge the risk of severe postoperative complications of patients by predicting probability risk. The invention is a high-precision, comprehensive and objective, easy-to-operate and intelligent risk assessment system.
Description
一、技术领域1. Technical field
本发明涉及一种用于医学的预测方法,具体涉及一种通过胃癌病人术前信息、手术信息、肿瘤病理信息来预测术后严重并发症风险度的方法。The invention relates to a prediction method used in medicine, in particular to a method for predicting the risk of severe postoperative complications through the preoperative information, operation information, and tumor pathological information of gastric cancer patients.
二、背景技术2. Background technology
在我国,胃癌是最常见的恶性肿瘤之一,其发病率及死亡率均居各种恶性肿瘤前列。胃癌的主要治疗方法是外科手术和辅助化疗,根治性胃癌手术是目前能够达到治愈目的的唯一治疗方法。标准的胃癌根治手术包括胃切除、淋巴结清扫和消化道重建3个内容,手术创伤大,操作复杂,由于我国的胃癌患者多为老年人,常有慢性并存病,肿瘤又以中晚期癌较为多见,故即使在手术经验丰富的大型医疗单位,胃癌术后严重并发症的发生率仍达10%~20%。常见的胃癌术后严重并发症如下:(一)严重感染,包括胸腔感染、腹腔感染、切口感染等;(二)肠梗阻,包括急性输入襻梗阻、吻合口梗阻、输出襻梗阻、胃瘫等;(三)瘘,包括胰瘘、吻合口瘘、十二指肠残端瘘等;(四)多器官功能障碍,包括心、肺、肝、肾等器官功能衰竭、应激性溃疡、DIC等。和其他手术相比,胃癌的术后严重并发症更具有其独特性和复杂性,一旦发生,临床处理极为棘手,治疗费用耗资巨大,重症者极易继发多器官功能衰竭而危及生命,病死率高达24%。因此,确定胃癌根治术后严重并发症的风险因素和风险度,具有十分重要的临床价值和社会价值。In my country, gastric cancer is one of the most common malignant tumors, and its morbidity and mortality rank among the forefront of various malignant tumors. The main treatment methods for gastric cancer are surgery and adjuvant chemotherapy. Radical gastric cancer surgery is currently the only treatment that can achieve the purpose of cure. The standard radical surgery for gastric cancer includes gastrectomy, lymph node dissection, and reconstruction of the digestive tract. The surgical trauma is large and the operation is complicated. Since most gastric cancer patients in my country are elderly, they often have chronic co-morbidities, and most of the tumors are middle-advanced cancers. See, even in large medical units with rich surgical experience, the incidence of serious complications after gastric cancer surgery is still as high as 10% to 20%. Common serious postoperative complications of gastric cancer are as follows: (1) severe infection, including chest infection, abdominal infection, incision infection, etc.; (2) intestinal obstruction, including acute input loop obstruction, anastomotic stoma obstruction, output loop obstruction, gastroparesis, etc. (3) Fistula, including pancreatic fistula, anastomotic fistula, duodenal stump fistula, etc.; (4) Multiple organ dysfunction, including heart, lung, liver, kidney and other organ failure, stress ulcer, DIC wait. Compared with other operations, severe postoperative complications of gastric cancer are more unique and complex. Once it occurs, the clinical treatment is extremely difficult, and the treatment costs are huge. In severe cases, multiple organ failure is easily secondary to life-threatening and death. rate as high as 24%. Therefore, it is of great clinical and social value to determine the risk factors and risk degree of severe complications after radical gastrectomy.
在胃癌术后严重并发症的风险因子确定及风险预测的研究领域,目前的国内外研究尚存在着诸多的缺陷:(1)有的研究者采集的致病因子少,参与病例少,不符合现代循证医学的核心要求之一,即临床证据要来自多中心、大样本的随机对照临床试验(RCT)、系统性评价(systematic review)和荟萃分析(meta-analysis);(2)有的研究者采用单因素分析方法,而胃癌术后严重并发症和众多致病因子之间的关系非常复杂,单因素分析无法在复杂的关系中平衡多种混杂因素的作用,也无法形成预测模型;(3)有的研究者采用多元线性回归分析方法,无法确定预测概率的最佳分界值,无法对建立的模型进行准确的验证和评价,实用性和可操作性差;而术后严重并发症和各种致病因子之间的关系实际上并非线性关系,同时,一个好的预测模型,必须要确定预测概率的最佳分界值,必须要通过严格的验证,证明其有较高的准确度、敏感度、特异度,并且要求操作简便,实用性强;(4)欲从对术后严重并发症有影响的众多因素中找出作用显著的因素,以达到疾病预后预测的目的,必须对传统预测方法作进一步的拓展,把统计学前沿的知识和思想引入到资料的分析方法之中。In the research field of risk factor determination and risk prediction of severe complications after gastric cancer surgery, there are still many shortcomings in the current research at home and abroad: (1) Some researchers collected few pathogenic factors and participated in fewer cases, which did not meet the One of the core requirements of modern evidence-based medicine, that is, clinical evidence should come from multi-center, large-sample randomized controlled clinical trials (RCT), systematic review (systematic review) and meta-analysis (meta-analysis); (2) some The researchers used a univariate analysis method, but the relationship between severe complications after gastric cancer surgery and many pathogenic factors is very complicated, and the univariate analysis cannot balance the effects of multiple confounding factors in the complex relationship, nor can it form a predictive model; (3) Some researchers use multiple linear regression analysis methods, unable to determine the optimal cut-off value of the prediction probability, unable to accurately verify and evaluate the established model, and have poor practicability and operability; severe postoperative complications and The relationship between various pathogenic factors is actually not a linear relationship. At the same time, a good prediction model must determine the best cut-off value of the prediction probability, and must pass strict verification to prove its high accuracy. Sensitivity, specificity, and requires simple operation and strong practicability; (4) To find out the significant factors from the many factors that affect the serious postoperative complications, in order to achieve the purpose of predicting the prognosis of the disease, it is necessary to analyze the traditional The prediction method is further expanded, and the knowledge and ideas of the frontier of statistics are introduced into the data analysis method.
三、发明内容3. Contents of the invention
本发明的目的在于提供一种胃癌术后严重并发症风险度的预测方法。本发明是通过对胃癌病人术前信息、手术信息、肿瘤病理信息等临床指标进行全面细致的回顾性调查,通过二值多元非条件逻辑回归(Logistic Regression)分析,确定胃癌术后严重并发症的主要危险因素,计算其相对危险度;通过受试者工作特征曲线(ROC)分析,确定最佳预测分界值,评价该预测方法的灵敏度、特异度;建立以主要危险因素为自变量的预测模型,从而为术后严重并发症风险度的评估提供客观依据,达到帮助病人进行医疗决策、辅助病房管理、指导医学临床研究等作用。The purpose of the present invention is to provide a method for predicting the risk of severe complications after gastric cancer surgery. The present invention conducts a comprehensive and detailed retrospective investigation of clinical indicators such as preoperative information, surgical information, and tumor pathological information of gastric cancer patients, and determines the severity of postoperative complications of gastric cancer through binary multivariate unconditional logistic regression (Logistic Regression) analysis. Calculate the relative risk of the main risk factors; determine the best prediction cut-off value through receiver operating characteristic curve (ROC) analysis, and evaluate the sensitivity and specificity of the prediction method; establish a prediction model with the main risk factors as independent variables , so as to provide an objective basis for the assessment of the risk of severe postoperative complications, and achieve the functions of helping patients make medical decisions, assisting ward management, and guiding medical clinical research.
为实现本发明所述目的,本发明提供一种利用二值多元非条件逻辑回归(LogisticRegression)分析技术和受试者工作特征曲线(ROC)分析技术来评估胃癌术后严重并发症风险度的方法,该预测方法包括以下步骤:In order to achieve the purpose of the present invention, the present invention provides a method for evaluating the risk of serious complications after gastric cancer surgery by using binary multiple unconditional logistic regression (LogisticRegression) analysis technology and receiver operating characteristic curve (ROC) analysis technology , the prediction method includes the following steps:
1.应用SPSS 13.0软件包建立胃癌信息数据库,所记录的79个变量指标如下:(1)连续性变量:淋巴结转移数目、淋巴结清扫数目、术中输血量、术中时间、肿瘤直径、年龄、血浆白蛋白、前白蛋白、肝功能Child-pugh评分、总胆红素、血红蛋白、白细胞计数、淋巴细胞计数、凝血酶原时间、血糖、癌胚抗原;(2)有序变量:淋巴结(LN)清扫度、手术根治度、T分期、N分期、TNM分期、肿瘤分化程度、Borrman分型;(3)二分类变量:第10组LN清扫、第11p组LN清扫、第12组LN清扫、第13组LN清扫、第14a组LN清扫、第14v组LN清扫、第15组LN清扫、第16a组LN清扫、第16b组LN清扫、联合脏器切除、联合肝叶切除、联合胆囊切除、联合脾切除、联合胰体尾及脾切除、联合Whipple手术、联合卵巢切除、联合横结肠切除、联合升降结肠切除、残胃切除、空肠营养造瘘、Broun吻合、浸润周围器官、浸润大网膜、浸润肝脏、浸润胆囊、浸润横结肠系膜、浸润横结肠、浸润胰头、浸润胰体尾、浸润脾脏、浸润食管、浸润十二指肠、远处器官转移、肝转移、腹膜转移、卵巢转移、广泛淋巴结转移、广泛腹腔转移、腹水、术前并存冠心病、严重心律失常、高血压病、慢阻肺、慢性肾功能不全、肝硬化、门静脉高压症、脑血管病、糖尿病、体重减轻、幽门梗阻、术前予营养支持、术后予营养支持等;(4)名义变量(需进行哑元化处理,转变为二分类变量):消化道重建方式、胃切除范围、肿瘤部位、组织类型;1. The SPSS 13.0 software package was used to establish a gastric cancer information database, and the recorded 79 variables were as follows: (1) Continuous variables: number of lymph node metastasis, number of lymph node dissection, intraoperative blood transfusion, intraoperative time, tumor diameter, age, Plasma albumin, prealbumin, Child-pugh score of liver function, total bilirubin, hemoglobin, white blood cell count, lymphocyte count, prothrombin time, blood sugar, carcinoembryonic antigen; (2) Ordinal variable: lymph node (LN ) degree of resection, degree of radical operation, T stage, N stage, TNM stage, degree of tumor differentiation, Borrman classification; (3) dichotomous variables: group 10 LN dissection, group 11p LN dissection, group 12 LN dissection, Group 13 LN dissection, Group 14a LN dissection, Group 14v LN dissection, Group 15 LN dissection, Group 16a LN dissection, Group 16b LN dissection, combined organ resection, combined liver lobectomy, combined cholecystectomy, Combined splenectomy, combined resection of the body and tail of the pancreas and splenectomy, combined Whipple operation, combined oophorectomy, combined transverse colectomy, combined ascending and descending colectomy, remnant gastrectomy, jejunostomy, Broun anastomosis, infiltration of peripheral organs, infiltration of omentum, Liver infiltration, gallbladder infiltration, transverse mesocolon infiltration, transverse colon infiltration, pancreas head infiltration, pancreas body and tail infiltration, spleen infiltration, esophagus infiltration, duodenum infiltration, distant organ metastasis, liver metastasis, peritoneal metastasis, ovarian metastasis, extensive Lymph node metastasis, extensive abdominal metastasis, ascites, preoperative coronary heart disease, severe arrhythmia, hypertension, chronic obstructive pulmonary disease, chronic renal insufficiency, liver cirrhosis, portal hypertension, cerebrovascular disease, diabetes, weight loss, pyloric obstruction , Nutritional support before operation, nutritional support after operation, etc.; (4) Nominal variables (need to be dummyized and transformed into binary variables): digestive tract reconstruction method, gastrectomy range, tumor location, tissue type;
2.先将所调查的79个变量指标进行单因素分析,相应的统计学处理方法如下:连续型变量采用独立样本T检验;有序变量采用非参数检验(Mann-Whitney U检验或Kolmogorov-Smirnov Z检验);二分类变量采用卡方检验或Fisher精确概率法;可信区间(CI)取95%,显著性差异取P≤0.05,结果筛选出18个差别有统计学意义的变量指标如下:联合胰体尾及脾切除、联合Whipple手术、Borrman分型、术中失血量、年龄、肿瘤直径、术中时间、肝功能Child-Pugh积分、术前慢性并存病、门静脉高压症、全胃切除、幽门梗阻、Nol6a组淋巴结清扫、No13组淋巴结清扫、肿瘤TNM分期、淋巴结清扫度、残胃切除、凝血酶原时间;2. Firstly, the 79 variable indicators investigated were subjected to univariate analysis, and the corresponding statistical processing methods were as follows: continuous variables were tested by independent sample T test; ordered variables were tested by non-parametric tests (Mann-Whitney U test or Kolmogorov-Smirnov Z test); dichotomous variables adopt chi-square test or Fisher's exact probability method; the confidence interval (CI) is 95%, and the significant difference is P≤0.05. As a result, 18 variables with statistically significant differences were screened out as follows: Combined pancreas tail and splenectomy, combined Whipple operation, Borrman classification, intraoperative blood loss, age, tumor diameter, intraoperative time, liver function Child-Pugh score, preoperative chronic coexisting diseases, portal hypertension, total gastrectomy , Pyloric obstruction, Nol6a group lymph node dissection, No13 group lymph node dissection, tumor TNM staging, degree of lymph node dissection, remnant gastrectomy, prothrombin time;
3.将筛选出的18个变量作二值多元非条件逻辑回归分析,进行模型检验,判别分析,计算各因素的偏回归系数和相对危险度:OR=Exp(B),得出8个真正影响胃癌术后严重并发症的因素如下:联合胰体尾及脾切除、淋巴结清扫度、肝功能Child-Pugh积分、术前慢性并存病、全胃切除、No16a组淋巴结清扫、术中失血量、肿瘤TNM分期;3. Perform binary multiple unconditional logistic regression analysis on the 18 variables screened out, carry out model testing, discriminant analysis, calculate the partial regression coefficient and relative risk of each factor: OR=Exp(B), and obtain 8 true The factors that affect the serious complications after gastric cancer surgery are as follows: combined pancreas body and tail and splenectomy, degree of lymph node dissection, Child-Pugh score of liver function, chronic coexisting diseases before operation, total gastrectomy, lymph node dissection in No16a group, intraoperative blood loss, Tumor TNM staging;
4.统计每位病人的术后并发症实际发生情况和预测概率,以预测概率为检验变量,以术后并发症实际发生情况为状态变量,作受试者工作特征曲线(ROC)分析,根据曲线下面积(Az)评价该预测方法的价值,根据尤登(Youden)指数确定最佳预测分界值,并评价该预测方法的灵敏度、特异度;4. Count the actual occurrence and predicted probability of postoperative complications for each patient, take the predicted probability as the test variable, and take the actual occurrence of postoperative complications as the state variable to perform receiver operating characteristic curve (ROC) analysis. The area under the curve (Az) evaluates the value of the prediction method, determines the best prediction cut-off value according to the Youden index, and evaluates the sensitivity and specificity of the prediction method;
5.根据上述步骤3的逻辑回归分析结果,建立胃癌术后严重并发症风险度的预测模型:P=Exp∑B0+B1X1+…+BkXk/1+Exp∑B0+B1X1+…+BkXk,其中P为应变量,代表风险概率值,X为自变量,代表各危险因子,B为偏回归系数,结合由尤登指数确定的最佳分界值,即可用于预测每例胃癌病人发生术后严重并发症的风险概率。5. According to the logistic regression analysis results of the above step 3, establish a prediction model for the risk of severe complications after gastric cancer surgery: P=Exp∑B0+B1X1+...+BkXk/1+Exp∑B0+B1X1+...+BkXk, where P is Response variable, representing risk probability value, X is independent variable, representing each risk factor, B is partial regression coefficient, combined with the optimal cut-off value determined by Youden index, it can be used to predict severe postoperative complications in each patient with gastric cancer risk probability.
本发明的有益效果如下:The beneficial effects of the present invention are as follows:
在医学实践中,某一疾病的发生往往是众多致病因素综合作用的结果,其中的因果关系错综复杂。逻辑回归(Logistic Regression)拟合方法进行多变量分析时,能在复杂的关系中平衡多种混杂因素的作用,筛选出的因素更为客观和可信,尤其适用于应变量为二分类变量、自变量为多个危险因素的临床资料,且该分析方法对资料数据的分布性限制很少,临床使用尤为方便。In medical practice, the occurrence of a certain disease is often the result of the combined action of many pathogenic factors, and the causal relationship is intricate. When the Logistic Regression (Logistic Regression) fitting method is used for multivariate analysis, it can balance the effects of multiple confounding factors in a complex relationship, and the screened factors are more objective and credible, especially suitable for dependent variables that are dichotomous variables, The independent variable is the clinical data of multiple risk factors, and the analysis method has few restrictions on the distribution of the data, so it is particularly convenient for clinical use.
受试者工作特征曲线(Receiver Operating Characteristic Curve,ROC)分析方法是以不同分界值时的敏感度和(1-特异度)分别作为纵坐标和横坐标,得出的一条曲线,通过测算曲线下的面积可以评价该预测系统的预测能力,并可根据尤登(Youden)指数,确定敏感度和特异度均较高的最佳的预测分界值。The receiver operating characteristic curve (Receiver Operating Characteristic Curve, ROC) analysis method is a curve obtained by using the sensitivity and (1-specificity) at different cut-off values as the vertical and horizontal coordinates respectively. The area of can be used to evaluate the prediction ability of the prediction system, and according to the Youden index, the best prediction cut-off value with high sensitivity and specificity can be determined.
本预测模型的变量指标都是高度客观的临床检验学、影像学、手术学、病理学指标,因此可靠性极强;通过拟合度检验(Goodness of fit test)和ROC分析,证实该预测模型具有高度的准确度、敏感度、特异度。The variable indicators of this prediction model are all highly objective clinical laboratory, imaging, surgery, and pathology indicators, so the reliability is extremely strong; the prediction model is confirmed by the Goodness of fit test and ROC analysis It has high accuracy, sensitivity and specificity.
该预测模型通过对胃癌术后严重并发症的风险度进行定量化分析,从而达到帮助病人进行医疗决策、辅助病房管理、指导医学临床研究等作用;同时,本套手术风险评估方法和模型建立方法,还可广泛应用于除胃癌以外的其他手术。The predictive model quantitatively analyzes the risk of serious complications after gastric cancer surgery, so as to help patients make medical decisions, assist ward management, and guide medical clinical research; at the same time, this set of surgical risk assessment methods and model establishment methods , and can also be widely used in operations other than gastric cancer.
帮助病人进行医疗决策:循证医学模式(Evidence-based medicine,EBM)是现代临床医学实践和研究的核心模式,循证医学的三大基本原则之一就是将患者作为医疗实践的主要参与者和决策者之一。医生的任何诊治决策的实施,都必须取得病人的理解和接受,都必须考虑到患者对该治疗方法的期望程度和经济承受能力。在临床实践中,对有些病人的手术注定是收效甚微,且由于术后严重并发症的发生,使得生命质量极差,最终的死亡仍不可避免,既加重了病人的痛苦,又造成了严重的医疗浪费。本预测模型通过对手术预后的客观预测,可帮助病人参与是否进行手术的医疗决策。Help patients make medical decisions: Evidence-based medicine (Evidence-based medicine, EBM) is the core model of modern clinical medical practice and research. One of the three basic principles of evidence-based medicine is to regard patients as the main participants in medical practice and one of the decision makers. The implementation of any diagnosis and treatment decision by a doctor must obtain the understanding and acceptance of the patient, and must take into account the patient's expectation and economic affordability of the treatment method. In clinical practice, the operation for some patients is doomed to have little effect, and due to the occurrence of serious postoperative complications, the quality of life is extremely poor, and the final death is still inevitable, which not only aggravates the pain of the patient, but also causes serious of medical waste. This prediction model can help patients participate in the medical decision-making of whether to perform surgery by objectively predicting the prognosis of surgery.
辅助病房管理:(1)决定病人的术后监护级别该预测模型对决定病人是否进入重症监护病房(ICU)有着独特的作用。据统计,目前国内的ICU病人中,低危的实际不需进入ICU的病人约占30%。本预测模型通过判别术后低危和高危病人,可帮助决定病人是否需要重症监护,及病房内每班所需要的护士和每个病人需要的护理等级。在医疗费用特别是重症监护治疗费用愈来愈昂贵的时代,本预测系统可显著减轻病人经济负担,并节省医疗资源;(2)在当前医疗现状中,医患纠纷激增,部分原因在于医生对手术的风险度缺乏客观、量化、准确度高的预测方法,使得病人对手术效果产生过高期待;通过手术风险预测系统,可帮助病人正确认识其手术危险,有助于缓解医患矛盾,减少医疗纠纷;(3)评价不同医疗机构、不同治疗小组之间的救治水平,分析有限的资源利用效率,乃至决定年度卫生财政预算等。Auxiliary ward management: (1) Determining the patient's postoperative care level This prediction model has a unique role in determining whether the patient is admitted to the intensive care unit (ICU). According to statistics, among the current domestic ICU patients, low-risk patients who actually do not need to enter the ICU account for about 30%. By identifying low-risk and high-risk postoperative patients, this predictive model can help determine whether a patient needs intensive care, as well as the number of nurses required for each shift in the ward and the level of care required for each patient. In an era when medical expenses, especially intensive care expenses, are becoming more and more expensive, this prediction system can significantly reduce the economic burden of patients and save medical resources; (2) In the current medical situation, doctor-patient disputes have surged, partly because doctors The risk of surgery lacks an objective, quantifiable, and highly accurate prediction method, which makes patients have high expectations for the effect of surgery; through the surgical risk prediction system, it can help patients correctly understand the risks of surgery, help alleviate the contradiction between doctors and patients, and reduce the risk of surgery. Medical disputes; (3) Evaluate the level of treatment among different medical institutions and different treatment groups, analyze the utilization efficiency of limited resources, and even determine the annual health budget.
指导医学临床研究,用于评价新的医疗手段:举例说明,我们选取预测术后死亡率为50~60%的病人分为两组,一组按传统处理,另一组除传统处理外,给予术后早期肠内营养支持(EN),结果发现后一组的实际死亡率降为30%,这表明EN可明显降低术后死亡率,值得推广。To guide medical clinical research and to evaluate new medical methods: for example, we select patients with a predicted postoperative mortality rate of 50-60% and divide them into two groups, one group is treated according to traditional methods, and the other group is treated with Early postoperative enteral nutrition support (EN), it was found that the actual mortality rate of the latter group was reduced to 30%, which indicated that EN can significantly reduce postoperative mortality and is worth popularizing.
四、附图说明4. Description of drawings
图1是本预测方法的受试者工作特征曲线(ROC曲线)。Figure 1 is the receiver operating characteristic curve (ROC curve) of this prediction method.
五、具体实施方式:5. Specific implementation methods:
实施例1:胃癌术后严重并发症风险度的预测方法,其方法步骤如下:Embodiment 1: A method for predicting the risk of serious complications after gastric cancer surgery, the method steps are as follows:
1.胃癌信息数据库的建立:1. Establishment of gastric cancer information database:
1.1临床资料来源:1.1 Sources of clinical data:
研究对象来源于2002年6月~2006年6月年在江苏省人民医院、南京大学鼓楼医院、南京军区总医院行胃癌手术的病人共1542例。采用回顾性病例一对照研究方法,病例组为手术后发生严重并发症者,对照组则来源于同期住院的无严重并发症的胃癌手术病人。The subjects of the study were 1542 patients who underwent gastric cancer surgery in Jiangsu Provincial People's Hospital, Drum Tower Hospital of Nanjing University, and General Hospital of Nanjing Military Region from June 2002 to June 2006. A retrospective case-control study was adopted. The case group consisted of patients with severe complications after surgery, and the control group consisted of gastric cancer surgery patients without serious complications who were hospitalized at the same time.
1.2调查内容所有临床资料信息以原始病历记录为准,采用统一的变量指标,全部输入以SPSS13.0统计软件包建立的胃癌信息数据库。共在体格检查信息、实验室检查信息、影像学检查信息、手术信息、肿瘤病理信息中选取79项指标作为可能的风险因子进行分析,包括:(1)连续性变量:淋巴结转移数目、淋巴结清扫数目、术中输血量、术中时间、肿瘤直径、年龄、血浆白蛋白、前白蛋白、肝功能Child-pugh评分、总胆红素、血红蛋白、白细胞计数、淋巴细胞计数、凝血酶原时间、血糖、癌胚抗原;(2)有序变量:淋巴结(LN)清扫度、手术根治度、T分期、N分期、TNM分期、肿瘤分化程度、Borrman分型;有序变量的分级标准见表1;(3)二分类变量:第10组LN清扫、第11p组LN清扫、第12组LN清扫、第13组LN清扫、第14a组LN清扫、第14v组LN清扫、第15组LN清扫、第16a组LN清扫、第16b组LN清扫、联合脏器切除、联合肝叶切除、联合胆囊切除、联合脾切除、联合胰体尾及脾切除、联合Whipple手术、联合卵巢切除、联合横结肠切除、联合升降结肠切除、残胃切除、空肠营养造瘘、Broun吻合、浸润周围器官、浸润大网膜、浸润肝脏、浸润胆囊、浸润横结肠系膜、浸润横结肠、浸润胰头、浸润胰体尾、浸润脾脏、浸润食管、浸润十二指肠、远处器官转移、肝转移、腹膜转移、卵巢转移、广泛淋巴结转移、广泛腹腔转移、腹水、术前并存冠心病、严重心律失常、高血压病、慢阻肺、慢性肾功能不全、肝硬化、门静脉高压症、脑血管病、糖尿病、体重减轻、幽门梗阻、术前予营养支持、术后予营养支持等;(4)名义变量:消化道重建方式、胃切除范围、肿瘤部位、组织类型等。对于名义变量,需进行哑元化处理,将其转换为多个二分类变量。然后检查多变量相关矩阵以考察共线性,如有证据表明存在严重的共线性,则进行变量删除。1.2 Survey content All clinical data and information are subject to the original medical records, using uniform variable indicators, and all are input into the gastric cancer information database established with the SPSS13.0 statistical software package. A total of 79 indicators were selected from physical examination information, laboratory examination information, imaging examination information, surgical information, and tumor pathology information as possible risk factors for analysis, including: (1) continuous variables: number of lymph node metastases, lymph node dissection Number, intraoperative blood transfusion volume, intraoperative time, tumor diameter, age, plasma albumin, prealbumin, liver function Child-pugh score, total bilirubin, hemoglobin, white blood cell count, lymphocyte count, prothrombin time, Blood glucose, carcinoembryonic antigen; (2) Ordinal variables: degree of lymph node (LN) dissection, degree of radical surgery, T stage, N stage, TNM stage, degree of tumor differentiation, Borrman classification; the grading standards of ordinal variables are shown in Table 1 (3) Dichotomous variables: Group 10 LN dissection, Group 11p LN dissection, Group 12 LN dissection, Group 13 LN dissection, Group 14a LN dissection, Group 14v LN dissection, Group 15 LN dissection, Group 16a LN dissection, Group 16b LN dissection, combined organ resection, combined hepatectomy, combined cholecystectomy, combined splenectomy, combined resection of the body and tail of pancreas and splenectomy, combined Whipple operation, combined oophorectomy, combined transverse colectomy, Combined ascending and descending colectomy, gastrectomy, jejunostomy, Broun anastomosis, invasion of peripheral organs, invasion of omentum, invasion of liver, invasion of gallbladder, invasion of transverse mesocolon, invasion of transverse colon, invasion of pancreatic head, invasion of pancreatic body and tail, invasion Spleen, infiltration of esophagus, infiltration of duodenum, distant organ metastasis, liver metastasis, peritoneal metastasis, ovarian metastasis, extensive lymph node metastasis, extensive abdominal cavity metastasis, ascites, preoperative coronary heart disease, severe arrhythmia, hypertension, chronic Pulmonary obstruction, chronic renal insufficiency, liver cirrhosis, portal hypertension, cerebrovascular disease, diabetes, weight loss, pyloric obstruction, preoperative nutritional support, postoperative nutritional support, etc.; (4) nominal variable: digestive tract reconstruction method , gastrectomy range, tumor location, tissue type, etc. For nominal variables, dummy processing is required to convert them into multiple binary variables. Multivariate correlation matrices were then examined for collinearity, and variable deletion was performed if there was evidence of severe collinearity.
表1有序变量的分级标准(部分)
1.3术后严重并发症的诊断标准和发生情况:1.3 Diagnostic criteria and occurrence of severe postoperative complications:
术后严重并发症定义为术后30天内发生的有潜在生命危险的并发症,包括:需再次手术的术后出血、肺部感染、肠瘘、心功能衰竭、急性肾功能衰竭等;手术死亡定义为术后30天内任何原因的死亡。Serious postoperative complications are defined as potentially life-threatening complications that occur within 30 days after surgery, including: postoperative hemorrhage requiring reoperation, pulmonary infection, intestinal fistula, heart failure, acute renal failure, etc.; surgical death Defined as death from any cause within 30 days postoperatively.
本组胃癌根治术后严重并发症发生率为17.6%(271/1542),发生频率依次为胸腔感染及胸腔积液、腹腔感染、动力性肠梗阻、切口感染、胰瘘、吻合口瘘、切口裂开、急性输入襻梗阻、十二指肠残端瘘、腹腔内出血、吻合口梗阻、多器官功能障碍(包括心、肺、肝、肾等器官功能不全)、应激性溃疡、胃瘫、急性胰腺炎、腹腔淋巴瘘、急性胆囊炎等,有些患者可出现多种严重并发症,手术死亡率为1.4%(21/1542)。The incidence rate of serious complications after radical gastrectomy in this group was 17.6% (271/1542), and the frequency of occurrence was pleural infection and pleural effusion, abdominal infection, dynamic ileus, incision infection, pancreatic fistula, anastomotic leakage, incision Dehiscence, acute input loop obstruction, duodenal stump fistula, intra-abdominal hemorrhage, anastomotic stoma obstruction, multiple organ dysfunction (including heart, lung, liver, kidney and other organ dysfunction), stress ulcer, gastroparesis, Acute pancreatitis, abdominal lymphatic fistula, acute cholecystitis, etc., some patients may have a variety of serious complications, and the operative mortality rate is 1.4% (21/1542).
2.单因素分析:2. Single factor analysis:
将所选79个变量作单因素分析,连续型变量采用独立样本T检验,有序变量采用非参数检验(Mann-Whitney U检验或Kolmogorov-Smirnov Z检验),二分类变量采用卡方检验或Fisher精确概率法,可信区间取95%,显著性差异取P≤0.05。统计结果(分别见表2、表3、表4)表明:在所分析的79个因素中有18个因素与胃癌根治术后严重并发症密切相关,分别为联合胰体尾及脾切除、联合Whipple手术、Borrman分型、术中失血量、年龄、肿瘤直径、术中时间、肝功能Child-Pugh积分、术前慢性并存病、门静脉高压症、全胃切除、幽门梗阻、No16a组淋巴结清扫、No13组淋巴结清扫、肿瘤TNM分期、淋巴结清扫度、残胃切除、凝血酶原时间。The selected 79 variables were used for univariate analysis. Continuous variables were tested by independent sample T test, ordinal variables were tested by non-parametric tests (Mann-Whitney U test or Kolmogorov-Smirnov Z test), and dichotomous variables were tested by Chi-square test or Fisher The exact probability method, the confidence interval is 95%, and the significant difference is P≤0.05. The statistical results (see Table 2, Table 3, and Table 4, respectively) showed that 18 of the 79 factors analyzed were closely related to severe complications after radical gastrectomy, namely, combined pancreatectomy and splenectomy, combined Whipple operation, Borrman classification, intraoperative blood loss, age, tumor diameter, intraoperative time, liver function Child-Pugh score, preoperative chronic coexisting diseases, portal hypertension, total gastrectomy, pyloric obstruction, No16a group lymph node dissection, No13 group lymph node dissection, tumor TNM staging, degree of lymph node dissection, remnant gastrectomy, prothrombin time.
表2连续性变量统计结果
表3二分类变量统计结果
表4等级资料的非参数检验结果
3.二值多元非条件逻辑回归分析3. Binary multiple unconditional logistic regression analysis
将初步筛选出的18个变量作二值多元非条件逻辑回归分析(后退法),进行模型检验,判别分析,计算各因素的偏回归系数和相对危险度:OR=Exp(B)。结果显示,共有8个因素进入逻辑回归模型,按作用强弱依次为:联合胰体尾及脾切除(OR=3.422)、淋巴结清扫度(OR=2.967)、肝功能Child-Pugh积分(OR=2.012)、术前慢性并存病(OR=1.961)、全胃切除(OR=1.501)、16a组淋巴结清扫(OR=1.391)、术中失血量(OR=1.207)、肿瘤TNM分期(OR=1.119)(表8)。模型检验结果(表5、6)表明:回归方程具有显著性意义;判别检验结果(表7)表明:模型具有较高的预测准确率(85.1%)。The 18 variables that were preliminarily screened out were subjected to binary multiple unconditional logistic regression analysis (regression method), model testing and discriminant analysis were performed to calculate the partial regression coefficient and relative risk of each factor: OR=Exp(B). The results showed that a total of 8 factors were entered into the logistic regression model, and the order of effect was: combined pancreas body and tail and splenectomy (OR=3.422), degree of lymph node dissection (OR=2.967), liver function Child-Pugh score (OR= 2.012), preoperative chronic comorbidity (OR=1.961), total gastrectomy (OR=1.501), 16a group lymph node dissection (OR=1.391), intraoperative blood loss (OR=1.207), tumor TNM staging (OR=1.119 ) (Table 8). The model test results (Table 5, 6) show that: the regression equation has significant significance; the discriminant test results (Table 7) show that: the model has a high prediction accuracy (85.1%).
表5模型检验1(拟合度检验)
表6模型检验2
表7判别检验表
表8二值多元非条件逻辑回归分析结果
4.受试者工作特征曲线(ROC)分析4. Receiver operating characteristic curve (ROC) analysis
统计每位病人的术后并发症实际发生情况和预测概率,以预测概率为检验变量,以术后并发症实际发生情况为状态变量,作受试者工作特征曲线分析,得到曲线下面积(Az);尤登(Youden)指数=敏感度+特异度-1,以尤登指数最大的一点判为预测概率的最佳分界值,结果如图一和表9所示:The actual occurrence and predicted probability of postoperative complications of each patient were counted, with the predicted probability as the test variable and the actual occurrence of postoperative complications as the state variable, the receiver operating characteristic curve was analyzed to obtain the area under the curve (Az ); Youden (Youden) index=sensitivity+specificity-1, with the maximum point of Youden index judged as the best cut-off value of prediction probability, the results are shown in Figure 1 and Table 9:
ROC曲线下面积(Az)为83.3%,表明预测模型有良好的预测价值(当Az为0.5~0.6时,表示预测价值低,Az为0.6~0.8时,表示预测价值中等,Az为0.8~1.0,表示预测价值高);与尤登指数最大点对应的临界值(P)为0.391(即当P<0.391时判为术后将不会发生严重并发症,当P>0.391时判为术后将发生严重并发症),此时,预测的敏感度为85.7%,特异度为78.6%。The area under the ROC curve (Az) is 83.3%, indicating that the prediction model has a good predictive value (when Az is 0.5-0.6, it means that the predictive value is low, when Az is 0.6-0.8, it means that the predictive value is medium, and when Az is 0.8-1.0 , indicating high predictive value); the critical value (P) corresponding to the maximum point of Youden’s index is 0.391 (that is, when P<0.391, it is judged that no serious complications will occur after surgery; when P>0.391, it is judged that postoperative Serious complications will occur), at this time, the predicted sensitivity is 85.7%, and the specificity is 78.6%.
表9根据尤登指数判定最佳预测概率分界值
进一步分析预测概率等级与术后严重并发症程度的关系(见表10),结果证实:预测概率(P值)等级愈高,术后严重并发症程度愈重,即风险愈高(P<0.001)。Further analysis of the relationship between the predicted probability grade and the degree of postoperative severe complications (see Table 10), the results confirmed that: the higher the predicted probability (P value) grade, the more serious the degree of postoperative severe complications, that is, the higher the risk (P<0.001 ).
表10模型概率等级与术后严重并发症程度的关系
5.建立胃癌术后严重严重并发症风险度的预测模型5. Establish a prediction model for the risk of severe complications after gastric cancer surgery
根据上述步骤3中的二值多元非条件逻辑回归分析结果,建立预测模型如下:P(1)=Exp∑(-2.942+1.23X1+0.021X2+0.009X3+1.041X4+0.892X5+0.804X6+0.003X7+0.016X8)/[1+Exp∑(-2.942+1.23X1+0.021X2+0.009X3+1.041X4+0.892X5+0.804X6+0.003X7+0.016X8)],设定预测概率分界值为0.391;当P<0.391时判为术后将不会发生严重并发症,当P>0.391时判为术后将发生严重并发症,P值越大,发生严重并发症的可能性越大。According to the binary multiple unconditional logistic regression analysis results in the above step 3, the prediction model is established as follows: P(1)=Exp∑(-2.942+1.23X1+0.021X2+0.009X3+1.041X4+0.892X5+0.804X6+ 0.003X7+0.016X8)/[1+Exp∑(-2.942+1.23X1+0.021X2+0.009X3+1.041X4+0.892X5+0.804X6+0.003X7+0.016X8)], set the prediction probability cut-off value to 0.391 ; When P<0.391, it is judged that there will be no serious complications after operation, and when P>0.391, it is judged that there will be serious complications after operation. The larger the P value, the greater the possibility of serious complications.
下面通过具体的病例对本发明作进一步的说明:Below by specific case the present invention will be further described:
某位胃癌病人的相关信息如下:根据病情,他(她)需要施行根治性全胃切除术(X5=1),联合胰体尾及脾切除(X1=1),淋巴结清扫度为D3(X2=3),腹主动脉周围淋巴结廓清(即No.16a组淋巴结需清扫,X6=1),其术前肝功能Child-Pugh评分为5分(X3=5),肿瘤病理分期为IIIA期(X8=4),如无术前慢性并存病(X4=0),术中失血量预计为200ml(X7=200),代入预测方程,得出P=0.680,由于P>0.391,故预测该病人有可能发生术后严重并发症,0.6<P<0.8,表明其发生严重并发症的危险度为中等。The relevant information of a patient with gastric cancer is as follows: According to the condition, he (she) needs to perform radical total gastrectomy (X5=1), combined with resection of the body and tail of the pancreas and splenectomy (X1=1), and the degree of lymph node dissection is D3 (X2 =3), lymph nodes around the abdominal aorta were dissected (that is, lymph nodes in No.16a group need to be dissected, X6=1), the Child-Pugh score of the preoperative liver function was 5 points (X3=5), and the pathological stage of the tumor was IIIA ( X8=4), if there is no chronic coexisting disease before operation (X4=0), the blood loss during operation is expected to be 200ml (X7=200), and it is substituted into the prediction equation to get P=0.680. Since P>0.391, it is predicted that the patient Severe postoperative complications may occur, 0.6<P<0.8, indicating that the risk of severe complications is moderate.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2006100982903A CN1973778A (en) | 2006-12-08 | 2006-12-08 | Method of predicting serious complication risk degree after gastric cancer operation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2006100982903A CN1973778A (en) | 2006-12-08 | 2006-12-08 | Method of predicting serious complication risk degree after gastric cancer operation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1973778A true CN1973778A (en) | 2007-06-06 |
Family
ID=38124328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2006100982903A Pending CN1973778A (en) | 2006-12-08 | 2006-12-08 | Method of predicting serious complication risk degree after gastric cancer operation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1973778A (en) |
Cited By (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102789536A (en) * | 2011-05-20 | 2012-11-21 | 中国人民解放军第二军医大学 | Method for establishing noninvasive evaluation model for liver surgical treatment risks |
| CN103488889A (en) * | 2013-09-18 | 2014-01-01 | 刘华锋 | Method and system of detecting artifacts in ICU patient records based on multivariate logistic regression |
| CN105431737A (en) * | 2013-04-05 | 2016-03-23 | 延世大学校产学协力团 | A system for predicting the prognosis of locally advanced gastric cancer |
| CN105474217A (en) * | 2013-06-24 | 2016-04-06 | 皇家飞利浦有限公司 | Predicted and tracked personalized patient treatment effects on body functions |
| CN106295179A (en) * | 2016-08-10 | 2017-01-04 | 广东工业大学 | A kind of influenza Forecasting Methodology and device |
| CN106667443A (en) * | 2017-01-10 | 2017-05-17 | 中山大学中山眼科中心 | Congenital cataract postoperative complication predicting method and system |
| US9672329B2 (en) | 2012-03-05 | 2017-06-06 | Opko Diagnostics, Llc | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| CN107586852A (en) * | 2017-11-06 | 2018-01-16 | 福建医科大学附属协和医院 | Gastric cancer peritoneum branch prediction model and its application based on 22 genes |
| CN107680680A (en) * | 2017-09-07 | 2018-02-09 | 广州九九加健康管理有限公司 | Cardiovascular and cerebrovascular disease method for prewarning risk and system based on accurate health control |
| CN108417267A (en) * | 2018-03-19 | 2018-08-17 | 首都医科大学附属北京地坛医院 | A system for determining short-term prognosis in patients with cirrhosis and hepatorenal syndrome |
| CN109155158A (en) * | 2015-11-05 | 2019-01-04 | 360膝盖系统股份有限公司 | Manage the patient of knee surgery |
| CN109480771A (en) * | 2018-10-17 | 2019-03-19 | 江西惠肽生物科技有限公司 | A kind of the determination method and determining device of the good evil of Ovarian Tumor |
| CN110634571A (en) * | 2019-09-20 | 2019-12-31 | 四川省人民医院 | Prognosis system after liver transplantation |
| CN110718283A (en) * | 2019-10-23 | 2020-01-21 | 上海中医药大学附属岳阳中西医结合医院 | Significance testing method for supplementary substitution |
| JP2020021371A (en) * | 2018-08-02 | 2020-02-06 | Necソリューションイノベータ株式会社 | Post-operative infection prediction device, post-operative infection prediction device production method, post-operative infection prediction method and program |
| CN110807785A (en) * | 2019-11-01 | 2020-02-18 | 上海理工大学 | A method to study the factors associated with postoperative recurrence in patients with non-small cell lung cancer |
| CN110827992A (en) * | 2019-11-15 | 2020-02-21 | 袁洪 | Preoperative prediction method for acute renal injury after hypertension operation |
| CN110930401A (en) * | 2019-12-11 | 2020-03-27 | 大连医科大学附属第一医院 | WHO/ISUP grading method for preoperative prediction of renal clear cell carcinoma by energy spectrum CT enhanced iodography imaging omics |
| CN110930402A (en) * | 2019-12-11 | 2020-03-27 | 大连医科大学附属第一医院 | A radiomic feature processing method based on DKI sequence MK map of endometrial cancer |
| CN110916666A (en) * | 2019-12-11 | 2020-03-27 | 大连医科大学附属第一医院 | A radiomics feature processing method for predicting recurrence of surgically resected hepatocellular carcinoma based on multimodal MRI images |
| CN111724903A (en) * | 2020-06-29 | 2020-09-29 | 北京市肿瘤防治研究所 | A system for predicting the prognosis of gastric cancer in subjects |
| CN111739642A (en) * | 2020-06-23 | 2020-10-02 | 杭州和壹医学检验所有限公司 | A colorectal cancer risk prediction method, system, computer device and readable storage medium |
| CN111899866A (en) * | 2020-07-28 | 2020-11-06 | 四川大学华西医院 | Evaluation system for surgical complications based on deep learning |
| CN112851793A (en) * | 2019-11-28 | 2021-05-28 | 北京肿瘤医院(北京大学肿瘤医院) | Marker and method for early diagnosis of infectious complications in body cavity |
| CN113053533A (en) * | 2021-03-17 | 2021-06-29 | 曜立科技(北京)有限公司 | Cardiovascular surgery risk assessment system based on big data analysis |
| CN113209402A (en) * | 2021-05-25 | 2021-08-06 | 重庆医科大学 | Risk prediction system and equipment for liver cirrhosis accompanied with spontaneous peritonitis |
| CN113436740A (en) * | 2021-07-03 | 2021-09-24 | 北京大学第三医院(北京大学第三临床医学院) | Construction method of prediction model of postoperative adverse outcome risk |
| CN113930506A (en) * | 2021-09-23 | 2022-01-14 | 江苏大学附属医院 | Glutamine metabolism gene label scoring system for predicting hepatocellular carcinoma prognosis and treatment resistance |
| CN114420291A (en) * | 2022-01-14 | 2022-04-29 | 安徽省肿瘤医院 | Lymph node metastasis risk assessment system and equipment for gastric cancer based on machine learning and storage medium |
| CN114783607A (en) * | 2022-05-10 | 2022-07-22 | 中南大学湘雅医院 | Surgical blood transfusion risk prediction model and construction method of network calculator thereof |
| CN115240854A (en) * | 2022-07-29 | 2022-10-25 | 中国医学科学院北京协和医院 | A method and system for processing pancreatitis prognosis data |
| US11761962B2 (en) | 2014-03-28 | 2023-09-19 | Opko Diagnostics, Llc | Compositions and methods related to diagnosis of prostate cancer |
| CN117116488A (en) * | 2023-10-23 | 2023-11-24 | 北京肿瘤医院(北京大学肿瘤医院) | Method and related equipment for evaluating postoperative serious complications of aged lung cancer patients |
| CN117198533A (en) * | 2023-09-11 | 2023-12-08 | 徐州医科大学 | Anesthesia risk assessment and early warning system for perioperative patients based on big data analysis |
| US11921115B2 (en) | 2015-03-27 | 2024-03-05 | Opko Diagnostics, Llc | Prostate antigen standards and uses thereof |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| RU2850369C1 (en) * | 2024-12-24 | 2025-11-11 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Method for predicting complications in the surgical treatment of patients with malignant neoplasms |
-
2006
- 2006-12-08 CN CNA2006100982903A patent/CN1973778A/en active Pending
Cited By (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102789536B (en) * | 2011-05-20 | 2015-11-18 | 中国人民解放军第二军医大学 | The method for building up of operation on liver Operative risk noninvasively estimating model |
| CN102789536A (en) * | 2011-05-20 | 2012-11-21 | 中国人民解放军第二军医大学 | Method for establishing noninvasive evaluation model for liver surgical treatment risks |
| TWI638277B (en) * | 2012-03-05 | 2018-10-11 | Opko診斷法有限責任公司 | Assy system and method for determining a probability of an event associated with prostate cancer |
| US10672503B2 (en) | 2012-03-05 | 2020-06-02 | Opko Diagnostics, Llc | Methods and apparatuses for conducting analyses |
| US12131802B2 (en) | 2012-03-05 | 2024-10-29 | Opko Diagnostics, Llc | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| CN108108590A (en) * | 2012-03-05 | 2018-06-01 | 阿克蒂克合伙公司 | Analysis system and method |
| CN104364788B (en) * | 2012-03-05 | 2018-02-06 | 阿克蒂克合伙公司 | Device to predict prostate cancer risk and prostate gland volume |
| US9672329B2 (en) | 2012-03-05 | 2017-06-06 | Opko Diagnostics, Llc | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| TWI596494B (en) * | 2012-03-05 | 2017-08-21 | Opko診斷法有限責任公司 | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| CN105431737A (en) * | 2013-04-05 | 2016-03-23 | 延世大学校产学协力团 | A system for predicting the prognosis of locally advanced gastric cancer |
| CN105431737B (en) * | 2013-04-05 | 2017-11-24 | 诺瓦米克斯有限公司 | A system for predicting the prognosis of locally advanced gastric cancer |
| CN105474217B (en) * | 2013-06-24 | 2018-09-18 | 皇家飞利浦有限公司 | A method and system for providing medical information for patients diagnosed with diseases |
| CN105474217A (en) * | 2013-06-24 | 2016-04-06 | 皇家飞利浦有限公司 | Predicted and tracked personalized patient treatment effects on body functions |
| CN103488889A (en) * | 2013-09-18 | 2014-01-01 | 刘华锋 | Method and system of detecting artifacts in ICU patient records based on multivariate logistic regression |
| US11761962B2 (en) | 2014-03-28 | 2023-09-19 | Opko Diagnostics, Llc | Compositions and methods related to diagnosis of prostate cancer |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| US11921115B2 (en) | 2015-03-27 | 2024-03-05 | Opko Diagnostics, Llc | Prostate antigen standards and uses thereof |
| CN109155158A (en) * | 2015-11-05 | 2019-01-04 | 360膝盖系统股份有限公司 | Manage the patient of knee surgery |
| CN106295179A (en) * | 2016-08-10 | 2017-01-04 | 广东工业大学 | A kind of influenza Forecasting Methodology and device |
| CN106667443A (en) * | 2017-01-10 | 2017-05-17 | 中山大学中山眼科中心 | Congenital cataract postoperative complication predicting method and system |
| CN107680680A (en) * | 2017-09-07 | 2018-02-09 | 广州九九加健康管理有限公司 | Cardiovascular and cerebrovascular disease method for prewarning risk and system based on accurate health control |
| CN107586852B (en) * | 2017-11-06 | 2021-01-29 | 福建医科大学附属协和医院 | Gastric cancer peritoneal metastasis prediction model based on 22 genes and application thereof |
| CN107586852A (en) * | 2017-11-06 | 2018-01-16 | 福建医科大学附属协和医院 | Gastric cancer peritoneum branch prediction model and its application based on 22 genes |
| CN108417267A (en) * | 2018-03-19 | 2018-08-17 | 首都医科大学附属北京地坛医院 | A system for determining short-term prognosis in patients with cirrhosis and hepatorenal syndrome |
| JP2020021371A (en) * | 2018-08-02 | 2020-02-06 | Necソリューションイノベータ株式会社 | Post-operative infection prediction device, post-operative infection prediction device production method, post-operative infection prediction method and program |
| JP7161688B2 (en) | 2018-08-02 | 2022-10-27 | Necソリューションイノベータ株式会社 | Post-surgery infection prediction device, post-surgery infection prediction device production method, post-surgery infection prediction method and program |
| CN109480771A (en) * | 2018-10-17 | 2019-03-19 | 江西惠肽生物科技有限公司 | A kind of the determination method and determining device of the good evil of Ovarian Tumor |
| CN109480771B (en) * | 2018-10-17 | 2021-09-07 | 江西惠肽生物科技有限公司 | Method and device for determining benign and malignant ovarian mass |
| CN110634571A (en) * | 2019-09-20 | 2019-12-31 | 四川省人民医院 | Prognosis system after liver transplantation |
| CN110718283A (en) * | 2019-10-23 | 2020-01-21 | 上海中医药大学附属岳阳中西医结合医院 | Significance testing method for supplementary substitution |
| CN110807785A (en) * | 2019-11-01 | 2020-02-18 | 上海理工大学 | A method to study the factors associated with postoperative recurrence in patients with non-small cell lung cancer |
| CN110827992A (en) * | 2019-11-15 | 2020-02-21 | 袁洪 | Preoperative prediction method for acute renal injury after hypertension operation |
| CN110827992B (en) * | 2019-11-15 | 2022-08-12 | 袁洪 | Preoperative prediction system for acute renal injury after hypertension operation |
| CN112851793B (en) * | 2019-11-28 | 2023-08-22 | 北京肿瘤医院(北京大学肿瘤医院) | Marker and method for diagnosing early-stage body cavity infectious complications |
| CN112851793A (en) * | 2019-11-28 | 2021-05-28 | 北京肿瘤医院(北京大学肿瘤医院) | Marker and method for early diagnosis of infectious complications in body cavity |
| CN110916666B (en) * | 2019-12-11 | 2023-03-21 | 大连医科大学附属第一医院 | Imaging omics feature processing method for predicting recurrence of hepatocellular carcinoma after surgical resection |
| CN110930401A (en) * | 2019-12-11 | 2020-03-27 | 大连医科大学附属第一医院 | WHO/ISUP grading method for preoperative prediction of renal clear cell carcinoma by energy spectrum CT enhanced iodography imaging omics |
| CN110930402A (en) * | 2019-12-11 | 2020-03-27 | 大连医科大学附属第一医院 | A radiomic feature processing method based on DKI sequence MK map of endometrial cancer |
| CN110916666A (en) * | 2019-12-11 | 2020-03-27 | 大连医科大学附属第一医院 | A radiomics feature processing method for predicting recurrence of surgically resected hepatocellular carcinoma based on multimodal MRI images |
| CN110930402B (en) * | 2019-12-11 | 2023-11-07 | 大连医科大学附属第一医院 | A radiomics feature processing method based on DKI sequence MK images of endometrial cancer |
| CN110930401B (en) * | 2019-12-11 | 2023-11-10 | 大连医科大学附属第一医院 | Energy spectrum CT enhanced iodigram imaging preacademic prediction kidney transparent cell carcinoma WHO/ISUP grading method |
| CN111739642A (en) * | 2020-06-23 | 2020-10-02 | 杭州和壹医学检验所有限公司 | A colorectal cancer risk prediction method, system, computer device and readable storage medium |
| CN111724903B (en) * | 2020-06-29 | 2023-09-26 | 北京市肿瘤防治研究所 | A system for predicting the prognosis of gastric cancer in subjects |
| CN111724903A (en) * | 2020-06-29 | 2020-09-29 | 北京市肿瘤防治研究所 | A system for predicting the prognosis of gastric cancer in subjects |
| CN111899866A (en) * | 2020-07-28 | 2020-11-06 | 四川大学华西医院 | Evaluation system for surgical complications based on deep learning |
| CN111899866B (en) * | 2020-07-28 | 2022-04-22 | 四川大学华西医院 | Surgical operation complication evaluation system based on deep learning |
| CN113053533A (en) * | 2021-03-17 | 2021-06-29 | 曜立科技(北京)有限公司 | Cardiovascular surgery risk assessment system based on big data analysis |
| CN113209402A (en) * | 2021-05-25 | 2021-08-06 | 重庆医科大学 | Risk prediction system and equipment for liver cirrhosis accompanied with spontaneous peritonitis |
| CN113436740A (en) * | 2021-07-03 | 2021-09-24 | 北京大学第三医院(北京大学第三临床医学院) | Construction method of prediction model of postoperative adverse outcome risk |
| CN113930506B (en) * | 2021-09-23 | 2022-10-18 | 江苏大学附属医院 | A glutamine metabolism gene signature scoring system for predicting prognosis and treatment resistance in hepatocellular carcinoma |
| CN113930506A (en) * | 2021-09-23 | 2022-01-14 | 江苏大学附属医院 | Glutamine metabolism gene label scoring system for predicting hepatocellular carcinoma prognosis and treatment resistance |
| CN114420291B (en) * | 2022-01-14 | 2023-04-07 | 安徽省肿瘤医院 | Lymph node metastasis risk assessment system and equipment for gastric cancer based on machine learning and storage medium |
| CN114420291A (en) * | 2022-01-14 | 2022-04-29 | 安徽省肿瘤医院 | Lymph node metastasis risk assessment system and equipment for gastric cancer based on machine learning and storage medium |
| CN114783607A (en) * | 2022-05-10 | 2022-07-22 | 中南大学湘雅医院 | Surgical blood transfusion risk prediction model and construction method of network calculator thereof |
| CN115240854B (en) * | 2022-07-29 | 2023-10-03 | 中国医学科学院北京协和医院 | A method and system for processing pancreatitis prognosis data |
| CN115240854A (en) * | 2022-07-29 | 2022-10-25 | 中国医学科学院北京协和医院 | A method and system for processing pancreatitis prognosis data |
| CN117198533A (en) * | 2023-09-11 | 2023-12-08 | 徐州医科大学 | Anesthesia risk assessment and early warning system for perioperative patients based on big data analysis |
| CN117116488A (en) * | 2023-10-23 | 2023-11-24 | 北京肿瘤医院(北京大学肿瘤医院) | Method and related equipment for evaluating postoperative serious complications of aged lung cancer patients |
| CN117116488B (en) * | 2023-10-23 | 2024-01-02 | 北京肿瘤医院(北京大学肿瘤医院) | A method and related equipment for assessing serious postoperative complications in elderly patients with lung cancer |
| RU2850369C1 (en) * | 2024-12-24 | 2025-11-11 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Method for predicting complications in the surgical treatment of patients with malignant neoplasms |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1973778A (en) | Method of predicting serious complication risk degree after gastric cancer operation | |
| Hua et al. | Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population | |
| Mofidi et al. | Risk assessment in acute pancreatitis | |
| Pedrazzani et al. | Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer | |
| Hirahara et al. | Preoperative geriatric nutritional risk index is a useful prognostic indicator in elderly patients with gastric cancer | |
| Gucu et al. | Prognostic nutritional index as a marker of mortality: an observational cohort study of patients undergoing cardiac surgery | |
| Al-Mazrou et al. | Alvimopan, regardless of ileus risk, significantly impacts ileus, length of stay, and readmission after intestinal surgery | |
| Li et al. | Gut microbiota patterns associated with somatostatin in patients undergoing pancreaticoduodenectomy: a prospective study | |
| Song et al. | Hypertriglyceridemia as a risk factor for complications of acute pancreatitis and the development of a severity prediction model | |
| Shoka et al. | Systemic inflammation score as a predictor of pneumonia after radical resection of gastric cancer: analysis of a multi-institutional dataset | |
| Jiang et al. | Nomogram for predicting transmural bowel infarction in patients with acute superior mesenteric venous thrombosis | |
| Jiang et al. | Explainable Machine Learning Model for Predicting Persistent Sepsis-Associated Acute Kidney Injury: Development and Validation Study | |
| Wang et al. | Clinical value on combined detection of serum CA724, DKK1, and TK1 in diagnosis of gastric cancer | |
| Zijlstra et al. | Progressive changes in platelet counts and Fib-4 scores precede the diagnosis of advanced fibrosis in NASH patients | |
| Luo et al. | The role of heart rate, body temperature, and respiratory rate in predicting anastomotic leakage following surgery for rectal cancer | |
| Haltmeier et al. | Transthyretin at Admission and Over Time as a Marker for Clinical Outcomes in Critically Ill Trauma Patients: A Prospective Single‐Center Study | |
| Dang et al. | How can we better predict the prognosis of patients with pancreatic cancer undergoing surgery using an immune-nutritional scoring system? | |
| Zheng et al. | Risk stratification models incorporating oxidative stress factors to predict survival and recurrence in patients with gastric cancer after radical gastrectomy: A real-world multicenter study | |
| Tan et al. | Right colonic perforation in an Asian population: predictors of morbidity and mortality | |
| Zhang et al. | Predictive role of preoperative hydronephrosis on poor pathological outcomes and prognosis in upper tract urothelial carcinoma patients: Experience from a nationwide high-volume center in China | |
| Abou Dagher et al. | The prognostic value of biomarker levels and chest imaging in patients with COVID-19 presenting to the emergency department | |
| Aoki et al. | Next endoscopic approach for acute lower gastrointestinal bleeding without an identified source on colonoscopy: upper or capsule endoscopy? | |
| Sinha et al. | Development and validation of parsimonious algorithms to classify ARDS phenotypes: secondary analyses of randomised controlled trials | |
| Hanna et al. | Defining the association between the prolonged operative time and 90-day complications in patients undergoing radical cystectomy | |
| Zou et al. | Association of albumin trajectories and cumulative exposure with in-hospital mortality in acute pancreatitis: a retrospective cohort study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |